TB Intensive San Antonio, Texas December 1-3, 2010

Similar documents
TB Intensive Tyler, Texas December 2-4, 2008

Utilizing All the Tools in the TB Toolbox

TB Classification (ATS/CDC)

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Diagnosis and Medical Management of Latent TB Infection

Treatment of Tuberculosis, 2017

Tuberculosis Tools: A Clinical Update

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

TB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012

Pulmonary Fascinomas with a Tuberculosis Attitude. Douglas Hornick, MD Medical Consultant Meeting November 29-30th, 2018.

DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

TB Nurse Case Management San Antonio, Texas April 9-11, 2013

Tuberculosis Intensive

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

INDEX CASE INFORMATION

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

has the following disclosures to make:

TB in Foreign Born and High Risk Populations

Latent TB Infection Treatment

Managing Complex TB Cases Diana M. Nilsen, MD, RN

Diagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease

Errors in Dx and Rx of TB

Managing the Patients Response to TB Treatment

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015

Diagnosis and Treatment of Tuberculosis, 2011

The Elimination of Tuberculosis. Richard E. Chaisson, MD. Center for TB Research Center for AIDS Research Johns Hopkins University

Tuberculosis Intensive November 17 20, 2015 San Antonio, TX

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2013

TB Intensive San Antonio, Texas August 7-10, 2012

Pre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI:

An Introduction to Radiology for TB Nurses

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1

Fundamentals of Tuberculosis (TB)

Contact Investigation and Prevention in the USA

5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH

Contact Investigation

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

3/25/2012. numerous micro-organismsorganisms

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

TB in the Correctional Setting Florence, Arizona October 7, 2014

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

TB Contact Investigation

TB Radiology for Nurses Garold O. Minns, MD

The Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer

TB Intensive Houston, Texas

Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012

Pediatric TB Intensive Houston, Texas October 14, 2013

Case 1: Clinical Presentation

Tuberculosis and Diabetes Dec. 10, 2009 Dean Schillinger, M.D. and Gisela Schecter, M.D., M.P.H. 1 of 18

TB Update: March 2012

TB Grand Rounds. Reynard McDonald, MD & Henry Fraimow, MD January 30, Outline

TB and Comorbidities Adriana Vasquez, MD April 12, 2018

The Epidemiology of Tuberculosis in Minnesota,

TB in the Patient with HIV

Patient History 1. Patient History 2. Social History. The Role of Surgery in the Management of TB. Reynard McDonald, MD & Paul Bolanowski, MD

A look at medical factors that increase the risk for TB disease

Role of Surgery in the Management of TB. Lee Reichman, MD & Paul Bolanowski, MD

Northwestern Polytechnic University

MEMORANDUM. Re: Guidance for follow-up of newly-arrived individual with Class B1 Tuberculosis Pulmonary Tuberculosis, no treatment

Patient Background. Role of Surgery in the Management of TB. Patient Background CXR 3/20/02

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Interpretation of Chest Radiographs Paul Christensen, MD 10/21/09. Diagnostic Evaluation. Medical Evaluation & CXR Interpretation.

My heart is racing. Managing Complex Cases. Case 1. Case 1

Disclosures. Current Issues and Controversies in Child and Adolescent Tuberculosis 02/24/2016. NSTC 2016 Annual Meeting

TUBERCULOSIS. Pathogenesis and Transmission

Pulmonary TB aspects

2018 Tuberculosis Clinical Intensive: Infection Prevention & Control. > No disclosures

State of the State in TB Control

Treatment of Tuberculosis

Diagnosis and Management of Latent TB Infection Douglas Hornick, MD September 27, 2011

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

TB Program Management San Antonio, Texas November 5-7, 2008

Dr Francis Ogaro MTRH ELDORET

Chest Radiology Interpretation: Findings of Tuberculosis

The diagnosis of active TB

Latent TB Infection (LTBI) Strategies for Detection and Management

Chapter 5 Treatment for Latent Tuberculosis Infection

Contact Investigation San Antonio, Texas January 14-15, 2013

PULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D.

Tuberculosis (TB) Fundamentals for School Nurses

Tuberculosis: A Provider s Guide to

The Dr. Jae Yang Lecture: An Overview of the Radiographic Picture of TB

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

Educational Objectives. Managing Lung Cancer From the Solitary Pulmonary Nodule to Complex Cases: A Multidisciplinary Approach.

LTBI Treatment and Anti TNF alpha

Use of the Cepheid GeneXpert to Release Patients from Airborne Isolation

TUBERCULOSIS AND THE TNF-α INHIBITORS. Lloyd Friedman, M.D. Yale University Milford Hospital

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

Treatment of Tuberculosis

Transcription:

TB Intensive San Antonio, Texas December 1-3, 2010 TB Case Presentations Doug Hornick, MD; Iowa U Medical School December 1, 2010 Pulmonary Fascinomas with a Tuberculous Attitude Douglas B. Hornick, MD Professor University of Iowa Carver College of Medicine Iowa City, Iowa 1

Disclaimers I am from Iowa More Hogs than people My clinical focus: chronic lung infections (eg, CF, bronchiectasis) TB has remained a hobby since medical school The cases I will share have been painstakingly researched, but have the answers? Purpose: share cases I found educational & get your feedback Learn from each other Ponder These Cases Proactive vs. Passive TB diagnosis University TB Thanks Dad Challenging TB or Not TB Old Friend It s back Paradox 2

What s This? This 75 yo man comes in to ER w/ dyspnea. From the CXR what is the diagnosis? 1. Aspergillosis 2. Active TB 3. Plombage 4. Squamous cell carcinoma 5. Wegener's granulomatosis Image Challenge. NEJM May 2009 Case 41 yo WF, rural Iowa, NH aid, HIV-, no IVDA, no travel 1995 PPD+, CXR normal, INH x6 mos 1999, 2000 Chest X-ray: bilateral UL infiltrates First Episode 12/01 Hemoptysis, smear/culture positive, CXR bilateral UL infiltrates No contact conversions outside of immediate family (no NH contacts) Rx (?DOT) x 6 months: INH 300, Rif 600, PZA 500 daily x 4 weeks INH 750, Rif 600, PZA 3000 twice/week x4 weeks 12 weeks smear & cultures negative INH 750, Rif 600 twice/week x16 weeks Relapse 8/02 Smear/culture positive Pansusceptible TB, No new cases in contacts & NH CXR bilateral UL infiltrates 3

Received standard ATS/IDSA/CDC Rx DOT x9 months Smear & Culture- by 4mos Asymptomatic 6 months after Rx completion Sputum smear/culture negative It s Back 12/05 (~3 years later) Relapse 2 Pan susceptible TB; DNA fingerprinting: all isolates identical No new cases in contacts & NH CXR bilateral UL infiltrates, RUL more dense & cavitary Analogous case: 31 yo Bosnian male, relapse 2 Well documented DOT for prior 2 Rx courses From a county w/ experience & good track record for DOT Complete immunodeficiency w/u nothing useful DNA fingerprinting: all isolates identical Do you see this? What would you do in these cases? Both patients received daily DOT x 12 mos (+PZA) 4

After r/o drug resistant TB, Other Suggestions Add PZA to regimen for increased intracellular therapeutic activity Check serum drug levels increased doses required Peloquin lab, National Jewish Check isolates against database strains which are prone to relapse (not d/t drug resistance, not necessarily related to virulence/contagion) Steve Holland lab, NIAID Patrick Moonan lab, CDC Thanks Dad 17 yo WF asymptomatic, HIV-, nonsmoker with positive TST SHx: Born raised in Iowa; No travel Household: Father with active extensively cavitary pulmonary, pan-susceptible TB undiagnosed for at least 3 months PMH: Unremarkable; No Medications Exam & Lab unremarkable Chest x-ray 5

Initial Chest X-Ray Neg. sputum smear x3 Other Diagnoses? Infection: Fungi, NTM Inflam.: Sarcoid, Wegener s Malignant What now? 4 Drugs DOT Two Month F/u Visit Lesion smaller; Tolerating Rx Negative AFB cultures x3 What now? INH, Rifampin DOT x2 mos? Yes: Smear-/Culture- TB 6

Six Months Post Rx Smear/Culture Negative Pulmonary TB Do not exclude TB diagnosis in highly suspect case 15-20% active TB cases in US culture negative Factors contributing to culture negative: Low # organisms in expectorated specimen (this case) Specimen processing error Consider alternative diagnosis Collect at least 3 specimens (>8 hrs apart, at least 1 AM); Consider Bronchoscopic sampling CDC/ATS/IDSA: TB Rx Rec AJRCCM 2003 7

Smear/Culture Negative Pulmonary TB Treatment Considerations Start 4 drugs DOT Acceptable: Abbreviate Continuation phase by 2 months Exception: Drug resistant contact or High risk for Drug Resistance Note: NYC Health Dept. recommends all pts continue 4 drugs x 6 months CDC/ATS/IDSA: TB Rx Rec AJRCCM 2003 Dutt AK et al. ARRD 1989 NYC Bureau of TB Control Website Accessed 9/09 Smear-, Culture- from India Suggest: NYC Heath Dept Approach 4 Drugs DOT x 6 months 8

Case 72 yo Algerian, asymptomatic, abnormal CXR More History Has lost 8kg over last 6 months Denies F/C/S, hemoptysis, chest pain PMH: 25 pk yr, quit x 10 yrs; DM; Htn; Chol; HIV neg Chest CT Not shown: 1-2 cm mediastinal LNs 9

Differential Diagnosis: Multiple Pulmonary Nodules Malignant: Metastatic Ca, Lymphoma, Inflammatory: Sarcoid, Wegener s, RA Infectious: Histo, TB, Cocci, Aspergillus, Worms, [HIV: Rhodococcus equi] Lab data: CRP 3.2 HIV neg Serology neg (RA, ANA, ANCA, Fungal titers What Now? Mediastinoscopy LN bx: Caseating Granulomas Cultures grew TB TB Multiple Pulmonary Nodules Disseminated TB nodules 1-4 mm = Miliary Tuberculomas 0.5-4 cm Multiple = Atypical & rare presentation PET CT likely would not have distinguished TB from malignant cause Concurrent mediastinal adenopathy suggestive of granulomatous disease DM a/w atypical TB presentation as with HIV & other immunocompromising conditions Fabrequet et al: Chest 2009;135:1094-97 10

Active TB? 19 yo student from Indonesia. Healthy, asymptomatic, denies HIV risk factors PMHx negative; No medications FH: Brother had active TB 2 years ago Student Health screen: TST+, IGRA+ Chest x-ray Radiologist Report: Scarring RUL Rule out TB What now? Chest CT? 11

Apical Lordotic view provides further confirmation Repeat CXR 5 days later after requesting re-do with shirt & neck ornamentation removed Not TB Latent TB Infection: 9 months Rx Abnormal X-ray report suggests TB?...Review film yourself (or with trusted clinician) Don t rush to Chest CT in uncertain TB cases Recall Apical Lordotic option Demonstrates Posterior/Apical Lung Segments Easily Done, Less Radiation, Less Costly 12